Completed PHASE1 INTERVENTIONAL 3-arm NCT04138836

Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

A 3-Part, Phase 1 Study to Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

Sponsor: Bridge Biotherapeutics, Inc.

Conditions Healthy Participants

Interventions BBT-877 Esomeprazole Itraconazole Midazolam

Updated 5 times since 2019 Last updated: Jan 15, 2020 Started: Sep 17, 2019 Primary completion: Nov 4, 2019 Completion: Nov 4, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Participants and is currently completed. Bridge Biotherapeutics, Inc. leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Feb 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Nov 2019 — Feb 2020 [monthly]

Active Not Recruiting PHASE1

First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bridge Biotherapeutics, Inc.
KCRN Research, LLC

Data source: Bridge Biotherapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lincoln, United States